EGCG pre-treatment alleviates LPS-induced acute lung injury (ALI) in mice through the inhibitory effect of protein kinase C alpha (PRKCA) on pro-inflammatory cytokine release through mitogen-activated protein kinase (MAPK) signaling pathways [53]. The gene discussed is PRKCA; the disease is acute lung injury.